1. Safety of two different doses of simvastatin plus rifaximin in decompensated cirrhosis (LIVERHOPE-SAFETY): a randomised, double-blind, placebo-controlled, phase 2 trial. (January 2020) Authors: Pose, Elisa; Napoleone, Laura; Amin, Ahmed; Campion, Daniela; Jimenez, César; Piano, Salvatore; Roux, Olivier; Uschner, Frank Erhard; de Wit, Koos; Zaccherini, Giacomo; Alessandria, Carlo; Angeli, Paolo; Bernardi, Mauro; Beuers, Ulrich; Caraceni, Paolo; Durand, François; Mookerjee, Rajeshwar P; T... Journal: Lancet gastroenterology and hepatology Issue: Volume 5:Number 1(2020) Page Start: 31 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗